Yunzhao Mo
Overview
Explore the profile of Yunzhao Mo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
71
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mo Y, Fan D, Wang W, Wang S, Yan Y, Zhao Z
Discov Oncol
. 2025 Feb;
16(1):154.
PMID: 39932605
Background: Patients with unmethylated O6-methylguanine-DNA methyltransferase promoter (uMGMT) glioblastoma (GBM) have a poor prognosis. Inflammatory response can affect the prognosis, for it may have a significant impact on the tumor...
2.
Ji J, Lian W, Zhang Y, Lin D, Wang J, Mo Y, et al.
Int J Pharm
. 2023 Mar;
636:122851.
PMID: 36931535
The postoperative thrombus attached to the damaged blood vessels severely obstructs drugs from crossing the damaged blood-brain barrier (BBB) and targeting residual glioma cells around surgical margins, leading to glioblastoma...
3.
Liu Y, Xu X, Zhang Y, Mo Y, Sun X, Shu L, et al.
Cell Death Dis
. 2022 Jun;
13(6):536.
PMID: 35676251
Glioblastoma multiforme (GBM) is the most aggressive and highly vascularized brain tumor with poor prognosis. Endothelial cell-dependent angiogenesis and tumor cell-dependent Vasculogenic mimicry (VM) synergistically contribute to glioma vascularization and...
4.
Zhang Y, Liu J, Mo Y, Chen Z, Chen T, Li Y, et al.
Stem Cells Int
. 2022 Apr;
2022:6430565.
PMID: 35463812
Mesenchymal stem cells (MSCs) have emerged as putative therapeutic tools due to their intrinsic tumor tropism, and anti-tumor and immunoregulatory properties. The limited passage and self-differentiation abilities of MSCs in...
5.
Li Y, Chen J, Chen Z, Xu X, Weng J, Zhang Y, et al.
Front Cell Dev Biol
. 2021 Sep;
9:663207.
PMID: 34540823
High-grade glioma is highly invasive and malignant, resistant to combined therapies, and easy to relapse. A better understanding of circular RNA (circRNA) biological function in high-grade glioma might contribute to...
6.
Deng S, Zheng Y, Mo Y, Xu X, Li Y, Zhang Y, et al.
World Neurosurg
. 2021 Jun;
152:e436-e448.
PMID: 34062295
Background: Glioblastoma (GBM) is the most lethal primary tumor in the central nervous system. Ferroptosis is a type of programmed iron-dependent cell death. In the present study, we aimed to...
7.
Jin L, Guo S, Zhang X, Mo Y, Ke S, Duan C
Neurosurg Rev
. 2020 Oct;
44(4):1943-1955.
PMID: 33037945
To compare the efficacy and safety of treatments based on the Stupp protocol for adult patients with newly diagnosed glioblastoma and to determine the optimal treatment option for patients with...